SUVENPHAR.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 12:00):

Stats
Dagens volum	387 440
Gjennomsnittsvolum	513 498
Markedsverdi	165.70B
EPS	INR0 ( 2024-02-05 )
Neste inntjeningsdato	( INR0 ) 2024-05-22
Last Dividend	INR5.00 ( 2022-09-09 )
Next Dividend	INR0 ( N/A )
P/E	44.64
ATR14	INR0.995 (0.16%)

Volum Korrelasjon

Lang: 0.00 (neutral)

Kort: -0.92 (very strong negative)

Signal:(21.534) Possible Trading Opportunity Present (swing)

Suven Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Suven Pharmaceuticals Korrelasjon - Valuta/Råvare

-0.04
( neutral )

-0.14
( neutral )

-0.44
( neutral )

0.00
( neutral )

0.04
( neutral )

-0.50
( neutral )

Suven Pharmaceuticals Økonomi

Annual	2022
Omsetning:	INR13.40B
Bruttogevinst:	INR7.55B (56.32 %)
EPS:	INR16.16

FY	2022
Omsetning:	INR13.40B
Bruttogevinst:	INR7.55B (56.32 %)
EPS:	INR16.16

FY	2022
Omsetning:	INR12.90B
Bruttogevinst:	INR7.35B (56.96 %)
EPS:	INR17.83

FY	2021
Omsetning:	INR9.80B
Bruttogevinst:	INR5.60B (57.12 %)
EPS:	INR14.23

Financial Reports:

No articles found.

Suven Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR5.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Suven Pharmaceuticals Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 2.52 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.000	2021-02-17
Last Dividend	INR5.00	2022-09-09
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	INR10.00	--
Avg. Dividend % Per Year	0.37%	--
Score	3.37	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	2.52
Div. Directional Score	7.26	--

Next Divdend (Est)
(2024-07-22)

INR0 Estimate 0.00 %

Dividend Stability

0.11 Bad

Dividend Score

3.37

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2021	INR2.00	0.43%
2022	INR8.00	1.62%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SMLT.NS	Dividend Knight	2023-08-09	Semi-Annually	3	0.64%
MIDHANI.NS	Dividend Junior	2023-09-22	Semi-Annually	7	1.04%
HAVELLS.NS	Dividend Junior	2023-06-02	Annually	23	0.43%
BECTORFOOD.NS	Dividend Junior	2023-09-22	Semi-Annually	4	0.39%
PUNJABCHEM.NS	Dividend Junior	2023-07-27	Sporadic	18	0.16%
KENNAMET.NS	Dividend Knight	2023-05-25	Annually	4	0.76%
ELECTCAST.NS	Dividend Junior	2023-09-04	Annually	23	1.51%
AHLUCONT.NS	Dividend Junior	2023-09-22	Sporadic	15	0.04%
SUNPHARMA.NS	Dividend Junior	2023-07-28	Semi-Annually	29	0.77%
NAVA.NS	Dividend Knight	2023-07-24	Annually	23	2.35%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.318	1.500	3.65	5.47	[0 - 0.5]
returnOnAssetsTTM	0.180	1.200	3.99	4.79	[0 - 0.3]
returnOnEquityTTM	0.201	1.500	8.88	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	26.98	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	20.95	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	17.94	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0168	-1.500	9.72	-10.00	[0 - 0.6]
interestCoverageTTM	94.82	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	3.86	2.00	8.71	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.86	2.00	8.07	10.00	[0 - 20]
debtEquityRatioTTM	0.0174	-1.500	9.93	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.587	1.000	3.55	3.55	[0.2 - 0.8]
operatingProfitMarginTTM	0.424	1.000	3.51	3.51	[0.1 - 0.6]
cashFlowToDebtRatioTTM	2.85	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.567	0.800	9.55	7.64	[0.5 - 2]
Total Score				12.00

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	44.27	1.000	5.63	0	[1 - 100]
returnOnEquityTTM	0.201	2.50	9.28	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.86	2.00	8.71	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.86	2.00	8.71	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-4.73	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0842	1.000	-0.396	0	[0.1 - 0.5]
Total Score				2.52

Suven Pharmaceuticals

Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is headquartered in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.